A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD) | MicrobiomeTrials← Back to trialsNCT07636811
A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-07-01Est. Completion: 2030-05-18
Enrollment target: 58 participants Locations- Clinical Study Site, Maitland, Florida, United States
- Clinical Study Site, Naples, Florida, United States
Other microbiome trials you might be interested in
Down SyndromeAlzheimer DiseaseDementia
The purpose of the Trial-Ready Cohort - Down Syndrome (TRC-DS) is to enroll 120 healthy adults with Down syndrome (DS), …
Phoenix, United StatesEst. completion Dec 31, 2027
Down SyndromeIntellectual Disability
Down syndrome (DS) is typically caused by an extra chromosome 21 in the cell nucleus (trisomy 21, or T21). T21 is both t…
Cleveland, United StatesEst. completion May 2028